Defective Medical Devices

Defective medical devices can cause injury and harm to unknowing patients. Medical device users expect treatments to work effectively and safely without undue risk or harm. Independent institutions, such as the Food and Drug Administration (FDA), place medical devices through extensive testing before releasing them to the consumer market. If potential risks and side effects are found, they are documented thoroughly and the user of the medical device is informed of any potential detriment to their health.

Regardless of this testing, medical devices are sometimes found to be faulty under certain circumstances or to raise the overall chance of illness or injury. The Guidant Defibrillator is one example of a defective medical device. Once installed, some models of the defibrillator run the risk of causing serious injury to the patient at an unknown time. Dealing with the risks associated with a defective medical device can have life-altering consequences.

In the event a defective medical device causes injury or death, the manufacturers of the device may be held legally liable for marketing a dangerous product. Some legal actions associated with defective medical devices evolve into class action or mass tort suits, whereby those affected by the hazardous devices can make a personal injury claim for a predetermined amount of compensation.

If you or a loved one has suffered an injury, illness, or death due to a defective medical device, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.

Defective Medical Devices

Links on the Web

MedWatch Safety Alert RSS Feed FDA MedWatch Safety Alerts

Wed, 01 Sep 2010 10:00:00 -0400 Tygacil (tigecycline): Label Change - Increased Mortality Risk Healthcare professionals should consider alternatives to Tygacil in patients with severe infections. Click here to read this Defective Medical Devices news article.

Thu, 26 Aug 2010 15:40:00 -0400 Huber Needles: Recall - Risk of Coring Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling through blood vessels into the patient?s lungs. Click here to read this Defective Medical Devices news article.

Thu, 26 Aug 2010 14:30:00 -0400 Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens Increase in reports of bloodborne infection transmission resulting from the shared use of fingerstick and point-of-care blood testing devices. Click here to read this Defective Medical Devices news article.

Wed, 25 Aug 2010 15:25:00 -0400 TimeOut Capsules: Undeclared Drug Ingredient Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil, a chemical similar to sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels. Click here to read this Defective Medical Devices news article.

Wed, 25 Aug 2010 12:38:00 -0400 MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient UPDATED 08/25/2010. Product marketed as dietary supplement contains undeclared Aminotadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels. Click here to read this Defective Medical Devices news article.

Wed, 25 Aug 2010 11:00:00 -0400 Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events. Click here to read this Defective Medical Devices news article.

Click here for archived Defective Medical Devices news.

National Institutes of Health (NIH) News Releases News Releases from the National Institutes of Health (NIH)

Thu, 02 Sep 2010 14:01:00 EDT NIH-sponsored research yields promising malaria drug candidate A chemical that rid mice of malaria-causing parasites after a single oral dose may eventually become a new malaria drug if further tests in animals and people uphold the promise of early findings. The compound, NITD609, was developed by an international team of researchers including Elizabeth A. Winzeler, Ph.D., a grantee of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Click here to read this Defective Medical Devices news article.

Thu, 02 Sep 2010 11:46:00 EDT Lower blood pressure goal benefits African-Americans with chronic kidney disease, protein in the urine On average, a lower blood pressure goal was no better than the standard blood pressure goal at slowing progression of kidney disease among African-Americans who had chronic kidney disease resulting from high blood pressure, according to results of the African-American Study of Kidney Disease and Hypertension (AASK), the largest and longest study of chronic kidney disease (CKD) in African-Americans. However, the blood pressure goal did benefit people who also had protein in the urine, which is a sign of kidney damage. The study, funded by the National Institutes of Health, appears in the Sept. 2 issue of the New England Journal of Medicine. Click here to read this Defective Medical Devices news article.

Thu, 02 Sep 2010 09:41:00 EDT New TB Diagnostic Proves Effective, Expedient, Study Finds A molecular test designed to easily diagnose tuberculosis (TB) and detect a drug-resistant form of the bacterium that causes TB can provide much more specific, sensitive and rapid results than currently available TB diagnostics, according to a new study in the New England Journal of Medicine. In a test involving 1,730 patients with suspected drug-sensitive or multidrug-resistant pulmonary TB, the Xpert MTB/RIF TB test successfully identified 98 percent of all confirmed TB cases and 98 percent of patients with rifampin-resistant bacteria in less than two hours. Click here to read this Defective Medical Devices news article.

Wed, 01 Sep 2010 16:41:00 EDT NIH awards grants to support biomedical research in space The National Institutes of Health announced today that it has awarded the first new grants under the Biomedical Research on the International Space Station (BioMed-ISS) initiative, a collaborative effort between NIH and NASA. Using a special microgravity environment that Earth-based laboratories cannot replicate, researchers will explore fundamental questions about important health issues, such as how bones and the immune system get weak. Click here to read this Defective Medical Devices news article.

Wed, 01 Sep 2010 16:36:00 EDT Association between elevated levels of lead, cadmium and delayed puberty in girls Researchers at the National Institutes of Health and other institutions have found that exposure to lead in childhood may delay the onset of puberty in young girls, with higher doses increasing the chance for later maturation. Click here to read this Defective Medical Devices news article.

Wed, 01 Sep 2010 14:31:00 EDT Third generation map of human genetic variation published An international consortium today published a third-generation map of human genetic variation, called the HapMap, which includes data from an additional seven global populations, increasing the total number to 11 populations. The improved resolution will help researchers interpret current genome studies aimed at finding common and rarer genetic variants associated with complex diseases. Click here to read this Defective Medical Devices news article.

Click here for archived Defective Medical Devices news.